PFIZER
Industry
Pharma
Agency
HCG
Year
2022-24
Pfizer is a leading global biopharmaceutical company committed to advancing science and bringing innovative medicines and vaccines to patients. By partnering with healthcare professionals and organizations worldwide, Pfizer aims to improve health outcomes and tackle some of today’s most urgent medical challenges.
Project
PAXLOVID
Year
2023
Brief
Pfizer needed to communicate the real-world impact and clinical efficacy of PAXLOVID, its COVID-19 antiviral treatment, to a professional healthcare audience. The goal was to build trust and drive awareness by sharing expert perspectives, while clearly conveying key data in an accessible, credible format.
Design
HCG produced a panel-style video featuring respected healthcare leaders discussing the outcomes, benefits, and clinical relevance of PAXLOVID. The format provided authentic, peer-to-peer insight, supported by compelling visual treatments to reinforce data points without distraction. The result was a clear, trustworthy, and informative resource tailored to the needs of clinicians evaluating treatment options during a critical time in public health.
Project
Medical Affairs Academy
Year
2023
Brief
Pfizer sought to develop a structured, engaging educational platform for internal teams and medical professionals—one that could effectively deliver complex scientific and clinical content while keeping users engaged over time.
Design
HCG collaborated with Pfizer’s medical leadership to produce and edit a series of educational videos for the Medical Affairs Academy. Videos featured Medical Leadership and KOLs delivering core scientific content in a clear, engaging format. By combining interviews with supporting visuals a create a professional, trustworthy learning experience that reflected Pfizer’s high standards and supported ongoing internal education across teams.